Brief: Active Biotech provides updated information about company's financial situation

Active Biotech AB publ

07/12/2017 18:17

Dec 7 (Reuters) - Active Biotech Ab  ACTI.ST : 
    * PROVIDES UPDATED INFORMATION ABOUT COMPANY'S FINANCIAL 
SITUATION 
    * BOARD HAS DECIDED TO SELL COMPANY'S PROPERTY IN LUND AS A 
POSSIBLE WAY OF GENERATING ADDITIONAL LIQUIDITY FOR COMPANY 
    * SALES PROCESS INITIATED BY BOARD REGARDING COMPANY'S 
PROPERTY 
IN LUND IS ONGOING BUT HAS NOT YET LED TO COMPLETION 
    * CURRENTLY HAS LIQUIDITY DEEMED NECESSARY TO FINANCE 
OPERATIONS 
UNTIL END OF Q2 OF 2018 
    * LOAN DEBT AMOUNTED TO SEK 210.8 MILLION ON SEPTEMBER 30, 
2017 
    * ACTIVE BIOTECH - UNLESS A SALE OF PROPERTY OR ANOTHER 
SOLUTION 
IS ACHIEVED, CO WILL LACK FUNDING TO ENSURE BUSINESS COMING 
TWELVE-MONTH PERIOD 
    * ACTIVE BIOTECH - ARPEGGIO STUDY RESULTS HAVE A DECISIVE 
NEGATIVE IMPACT ON CONTINUED DEVELOPMENT OF LAQUINIMOD IN PPMS 
 
Source text for Eikon:  ID:nGNE13ty2q  
Further company coverage:  ACTI.ST  
 
 ((Bangalore.newsroom@thomsonreuters.com;))